Reference
SERMO. New Poll Finds 64 Percent of Global Doctors Believe New Hepatitis C Drugs are Worth the Cost. Internet Document : 21 Jul 2016. Available from: URL: http://www.sermo.com/media/press-releases-view/83
Rights and permissions
About this article
Cite this article
Many doctors consider price of new hepatitis C drugs justified. PharmacoEcon Outcomes News 759, 5 (2016). https://doi.org/10.1007/s40274-016-3270-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3270-3